These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12559847)

  • 41. Crystallization and preliminary crystallographic analysis of human alanine:glyoxylate aminotransferase and its polymorphic variants.
    Zhang X; Roe SM; Pearl LH; Danpure CJ
    Acta Crystallogr D Biol Crystallogr; 2001 Dec; 57(Pt 12):1936-7. PubMed ID: 11717523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1.
    Leiper JM; Oatey PB; Danpure CJ
    J Cell Biol; 1996 Nov; 135(4):939-51. PubMed ID: 8922378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I.
    Oppici E; Montioli R; Dindo M; Maccari L; Porcari V; Lorenzetto A; Chellini S; Voltattorni CB; Cellini B
    ACS Chem Biol; 2015 Oct; 10(10):2227-36. PubMed ID: 26161999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An intronic duplication in the alanine: glyoxylate aminotransferase gene facilitates identification of mutations in compound heterozygote patients with primary hyperoxaluria type 1.
    Purdue PE; Lumb MJ; Allsop J; Danpure CJ
    Hum Genet; 1991 Aug; 87(4):394-6. PubMed ID: 1879825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview.
    Oppici E; Montioli R; Cellini B
    Biochim Biophys Acta; 2015 Sep; 1854(9):1212-9. PubMed ID: 25620715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis.
    Monico CG; Rossetti S; Schwanz HA; Olson JB; Lundquist PA; Dawson DB; Harris PC; Milliner DS
    J Am Soc Nephrol; 2007 Jun; 18(6):1905-14. PubMed ID: 17460142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular etiology of primary hyperoxaluria type 1: new directions for treatment.
    Danpure CJ
    Am J Nephrol; 2005; 25(3):303-10. PubMed ID: 15961951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human liver peroxisomal alanine:glyoxylate aminotransferase: characterization of the two allelic forms and their pathogenic variants.
    Cellini B; Montioli R; Voltattorni CB
    Biochim Biophys Acta; 2011 Nov; 1814(11):1577-84. PubMed ID: 21176891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.
    Danpure CJ
    Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I.
    Cellini B; Montioli R; Paiardini A; Lorenzetto A; Maset F; Bellini T; Oppici E; Voltattorni CB
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2896-901. PubMed ID: 20133649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The major allele of the alanine:glyoxylate aminotransferase gene: seven novel mutations causing primary hyperoxaluria type 1.
    Coulter-Mackie MB; Applegarth D; Toone JR; Henderson H
    Mol Genet Metab; 2004 May; 82(1):64-8. PubMed ID: 15110324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.
    Oppici E; Montioli R; Lorenzetto A; Bianconi S; Borri Voltattorni C; Cellini B
    Mol Genet Metab; 2012 Jan; 105(1):132-40. PubMed ID: 22018727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B
    Dindo M; Oppici E; Dell'Orco D; Montone R; Cellini B
    J Inherit Metab Dis; 2018 Mar; 41(2):263-275. PubMed ID: 29110180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria.
    Pelle A; Cuccurullo A; Mancini C; Sebastiano R; Stallone G; Negrisolo S; Benetti E; Peruzzi L; Petrarulo M; De Marchi M; Marangella M; Amoroso A; Giachino D; Mandrile G
    J Nephrol; 2017 Apr; 30(2):219-225. PubMed ID: 26946417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1.
    Miyata N; Steffen J; Johnson ME; Fargue S; Danpure CJ; Koehler CM
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14406-11. PubMed ID: 25237136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel mutation in the AGXT gene causing primary hyperoxaluria type I: genotype-phenotype correlation.
    M'Dimegh S; Aquaviva-Bourdain C; Omezzine A; M'Barek I; Souche G; Zellama D; Abidi K; Achour A; Gargah T; Abroug S; Bouslama A
    J Genet; 2016 Sep; 95(3):659-66. PubMed ID: 27659337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Partial deletion of the AGXT gene (EX1_EX7del): A new genotype in hyperoxaluria type 1.
    Nogueira PK; Vuong TS; Bouton O; Maillard A; Marchand M; Rolland MO; Cochat P; Bozon D
    Hum Mutat; 2000 Apr; 15(4):384-5. PubMed ID: 10737993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutation-based diagnostic testing for primary hyperoxaluria type 1: survey of results.
    Coulter-Mackie MB; Lian Q; Applegarth DA; Toone J; Waters PJ; Vallance H
    Clin Biochem; 2008 May; 41(7-8):598-602. PubMed ID: 18282470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1.
    Dindo M; Grottelli S; Annunziato G; Giardina G; Pieroni M; Pampalone G; Faccini A; Cutruzzolà F; Laurino P; Costantino G; Cellini B
    Biochem J; 2019 Dec; 476(24):3751-3768. PubMed ID: 31794008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crystal structure of the S187F variant of human liver alanine: glyoxylate [corrected] aminotransferase associated with primary hyperoxaluria type I and its functional implications.
    Oppici E; Fodor K; Paiardini A; Williams C; Voltattorni CB; Wilmanns M; Cellini B
    Proteins; 2013 Aug; 81(8):1457-65. PubMed ID: 23589421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.